Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives (Q35938663)

11 August 2017

1 reference

title

Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives (English)

1 reference

11 August 2017

Peter Birkenhauer

1

1 reference

11 August 2017

Zhihong Yang

series ordinal

2

1 reference

11 August 2017

Bruno Gander

series ordinal

3

1 reference

11 August 2017

language of work or name

1 reference

1 November 2004

1 reference

Journal of Pharmacy and Pharmacology

11 August 2017

published in

1 reference

11 August 2017

volume

56

1 reference

11 August 2017

issue

11

1 reference

11 August 2017

page(s)

1339-1356

1 reference

Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

First human experience with the 17-beta-estradiol-eluting stent: the Estrogen And Stents To Eliminate Restenosis (EASTER) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Stent-based immunosuppressive therapies for the prevention of restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

The WRIST series--what have we learnt?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Stent-induced restenosis in the swine coronary artery is inhibited by a platelet-derived growth factor receptor tyrosine kinase inhibitor, TKI963.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Advances in coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

ABT-578-eluting stents. The promising successor of sirolimus- and paclitaxel-eluting stent concepts?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Vascular endothelial growth factor enhances atherosclerotic plaque progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Inhibition of vascular endothelial growth factor-mediated neointima progression with angiostatin or paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Sustained local drug delivery to the arterial wall via biodegradable microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

The bigger, the better: true also for in-stent restenosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

A morphological-mechanical explanation of edge restenosis in lesions treated with vascular brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Predicting the future of human gene therapy for cardiovascular diseases: what will the management of coronary artery disease be like in 2005 and 2010?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Predicting restenosis: bigger is better but not best

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Overview of therapies for prevention of restenosis after coronary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Compensatory enlargement of human atherosclerotic coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Impact of lesion complexity on the capacity of a trial to detect differences in stent performance: results from the ISAR-STEREO trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Radioactive stents: problems and potential solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor Effect of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Evaluation of a high-dose dexamethasone-eluting stent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Mechanisms of resistance to rapamycins

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Molecular mechanisms of in-stent restenosis and approach to therapy with eluting stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Comparative trial of local pharmacotherapy with L-arginine, r-hirudin, and molsidomine to reduce restenosis after balloon angioplasty of stenotic rabbit iliac arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Gene therapy for restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

A case of Cypher restenosis treated with gamma radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Defining coronary restenosis. Newer clinical and angiographic paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Cyclic Stretching Stimulates Synthesis of Matrix Components by Arterial Smooth Muscle Cells in Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Study of antirestenosis with the BiodivYsio dexamethasone‐eluting stent (STRIDE): A first‐in‐human multicenter pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Coronary in-stent restenosis: current status and future strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Bench to bedside: the development of rapamycin and its application to stent restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Sirolimus-eluting coronary stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Preclinical evaluation of inducible nitric oxide synthase lipoplex gene therapy for inhibition of stent-induced vascular neointimal lesion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Growth inhibition of human vascular smooth muscle cells by fenofibrate: a possible therapy for restenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Rapamycin inhibits vascular smooth muscle cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Overcoming restenosis with sirolimus: from alphabet soup to clinical reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Infectious agents in coronary lesions obtained by endatherectomy: pattern of distribution, coinfection, and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Local delivery of NO-donor molsidomine post-PTA improves haemodynamics, wall mechanics and histomorphometry in atherosclerotic porcine SFA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Histopathology of postpercutaneous transluminal coronary angioplasty remodeling in human coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Cytomegalovirus, Chlamydia pneumoniae, and Helicobacter pylori IgG antibodies and restenosis after stent implantation: an angiographic and intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Comparison of initial efficacy and long-term follow-up of heparin-coated Jostent with conventional NIR stent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Stenting of coronary arteries: has a modern Pandora's box been opened?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Intracoronary radiation therapy in controlled and open clinical trials with afterloading systems and "hot" balloon catheters. Analysis of 6,692 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Antiproliferative coated stents and intracoronary brachytherapy: common traits and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Paclitaxel-eluting stents: are they all equal? An analysis of six randomized controlled trials in de novo lesions of 3,319 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Effect on intimal hyperplasia of dexamethasone released from coated metal stents compared with non-coated stents in canine femoral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Deleterious effect of coronary brachytherapy on vasomotor response to exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings: the Tenax versus Nir Stent Study's long-term outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

The influence of low molecular weight heparin on neointimal proliferation in cultured human saphenous vein

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Intra-arterial beta irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Histopathologic alterations after endovascular radiation and antiproliferative stents: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Corticosteroid agents inhibit proliferation of smooth muscle cells from human atherosclerotic arteries in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Therapeutic angiogenesis: a complex problem requiring a sophisticated approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Leukocyte recruitment and expression of chemokines following different forms of vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

The effect of low molecular weight heparin on intimal hyperplasia in vein grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

The influence of smoking and lipids on restenosis after carotid endarterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Sustained Local Delivery of Dexamethasone by a Novel Intravascular Eluting Stent to Prevent Restenosis in the Porcine Coronary Injury Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the PlA2allele of the platelet glycoprotein IIIa gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044797

21 January 2018

Identifiers

DOI

10.1211/0022357044797

1 reference

release_uixuk56aira4bifxl5mvjg2jee

11 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uixuk56aira4bifxl5mvjg2jee

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference